Conduction disorders following transcatheter aortic valve replacement using acurate Neo2 transcatheter heart valve: A propensity matched analysis.
暂无分享,去创建一个
I. Barbash | D. Dvir | Y. Arbel | A. Steinvil | A. Halkin | S. Banai | Jeremy Ben-Shoshan | A. Finkelstein | G. Elbaz‐Greener | Itamar Loewenstein | Maayan Konigstein | Ran Kornowski | Elad Asher | Amit Segev | Planner David | Hana Assa-Vaknin
[1] S. Toggweiler,et al. ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2. , 2024, International journal of cardiology.
[2] M. Joner,et al. Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves , 2023, Clinical research in cardiology : official journal of the German Cardiac Society.
[3] P. Teirstein,et al. Three-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis. , 2023, Journal of the American College of Cardiology.
[4] C. Terkelsen,et al. Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicenter, observational, post-market surveillance study. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] P. Pibarot,et al. Impact of Paravalvular Leak on Outcomes After Transcatheter Aortic Valve Implantation: Meta-Analysis of Kaplan-Meier-derived Individual Patient Data , 2022, Structural heart : the journal of the Heart Team.
[6] M. Joner,et al. ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] R. Kornowski,et al. Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[8] D. Wood,et al. Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] C. Cuccia,et al. Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes. , 2022, JACC. Cardiovascular interventions.
[10] V. Guetta,et al. Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve Replacement. , 2022, The Journal of invasive cardiology.
[11] H. Baumgartner,et al. Pacemaker implantation rate after TAVI with the latest generation balloon-expandable valve SAPIEN 3 Ultra , 2021, European Heart Journal.
[12] P. Serruys,et al. Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE neo2 versus ACURATE neo Transcatheter Aortic Valve Implantation , 2021, Journal of clinical medicine.
[13] M. Joner,et al. The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes , 2021, Clinical Research in Cardiology.
[14] D. Wood,et al. Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years. , 2021, JACC. Cardiovascular interventions.
[15] M. Niemelä,et al. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement. , 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] C. Hengstenberg,et al. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis , 2020, Circulation.
[17] B. Ghanim,et al. Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies , 2020, Scientific Reports.
[18] P. Stella,et al. Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[19] M. Dalby,et al. Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry. , 2020, International journal of cardiology.
[20] D. Wood,et al. Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry). , 2020, American Journal of Cardiology.
[21] T. Nazif,et al. Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. , 2020, JACC. Cardiovascular interventions.
[22] P. Leprince,et al. Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement , 2019, Circulation.
[23] B. Prendergast,et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.
[24] J. Leipsic,et al. Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.
[25] Andrew S. Mugglin,et al. Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.
[26] I. Barbash,et al. Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry , 2018, Clinical Research in Cardiology.
[27] R. Kobza,et al. Pacemaker implantation after transcatheter aortic valve: why is this still happening? , 2018, Journal of thoracic disease.
[28] R. Kobza,et al. Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[29] D. Berman,et al. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. , 2017, JACC. Cardiovascular imaging.
[30] J. Chambers,et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, European heart journal cardiovascular Imaging.
[31] Y. Arbel,et al. Comparison of the Edwards SAPIEN S3 Versus Medtronic Evolut-R Devices for Transcatheter Aortic Valve Implantation. , 2017, The American journal of cardiology.
[32] E. Tuzcu,et al. Clinical ResearchInterventional CardiologyIncidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Systematic Review of Literature , 2013 .
[33] S. Windecker,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[34] Scott Lim,et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.
[35] R. D'Agostino. Propensity Scores in Cardiovascular Research , 2007, Circulation.